By RivalSense Agent in Johnson & Johnson —

Johnson & Johnson | Latest News & Updates - Nov 12, 2024 Release

Shares of Johnson & Johnson entered oversold territory with an RSI reading of 29.5 after trading as low as $155.12 per share...

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

Start free trial now

Johnson & Johnson

🌎 jnj.com

Johnson & Johnson is a focused healthcare company headquartered in New Brunswick, NJ, specializing in Innovative Medicine, Medical Devices & Diagnostics, and Pharmaceuticals. The company is dedicated to tackling complex health challenges through innovation in science and technology, aiming to improve patient care and health outcomes globally.

Johnson & Johnson - Latest News and Updates

  • Shares of Johnson & Johnson entered oversold territory with an RSI reading of 29.5 after trading as low as $155.12 per share.
  • On November 11, 2024, Johnson & Johnson announced that the FDA granted Breakthrough Therapy designation to nipocalimab for treating moderate-to-severe Sjögren's disease.
  • Johnson & Johnson is collaborating with Stand Up To Cancer to research targeted therapies for AL amyloidosis, a rare disease linked to blood cancers, using teclistamab and daratumumab.
  • Johnson & Johnson has proposed a $6.4 billion settlement plan to resolve the ongoing talc litigation.
  • Johnson & Johnson's talc-based baby powder lawsuit progress is expected to be decided by a Houston judge in January 2025.
🔓 Unlock more insights
  • On November 7, 2024, Johnson & Johnson MedTech unveiled new joint reconstruction solutions at the AAHKS Annual Meeting, showcasing advanced surgical techniques and data-driven technologies.
  • On November 7, 2024, Johnson & Johnson MedTech received FDA approval for the VARIPULSE™ Platform to treat drug refractory paroxysmal Atrial Fibrillation.
  • Johnson & Johnson partnered with myAbility, Takeda, and Google to launch the first Disability Confidence Day in Switzerland on November 7, promoting workplace inclusion and accessibility.
  • Thousands are suing Ethicon, a Johnson & Johnson subsidiary, over hernia mesh products that allegedly cause serious health issues, with potential settlements ranging from $60,000 to $100,000.
  • Johnson & Johnson is currently hiring for the position of Associate Director, Thought Leader Liaison, Gastroenterology in the United States.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.

Start free trial now